Piper Jaffray Maintains PT, Rating Following Investor Meetings At DVA

Piper Jaffray is maintaining its Overweight rating and its $95 price target on DaVita DVA following investor meetings with the company's management. Says Piper Jaffray, in its report, “We are incrementally more confident in our outlook and positive thesis on DaVita following a day of investor meetings with management. CFO Luis Borgen provided investors with a positive update on the company's capital deployment strategies, laid out confident expectations for a relatively stable pricing environment over the next several years, and expressed optimism over the company's long-term OUS growth strategy. We reiterate our Overweight rating on DVA as it is one of the most stable and defensive stocks in our coverage universe.” DVA closed at $70.59 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care ServicesPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!